Advanced search
Publication Cover
Current Medical Research and Opinion Volume 34, 2018 - Issue 6: Diabetes
Submit an article Journal homepage
555
Views
18
CrossRef citations to date
0
Altmetric
Diabetes

Pharmacy-based predictors of non-persistence with and non-adherence to statin treatment among patients on oral diabetes medication in the Netherlands

Sofa D. AlfianUnit of PharmacoTherapy, -Epidemiology, & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands; ;Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Indonesia; Correspondence[email protected]
,
Pawida WorawutputtapongUnit of PharmacoTherapy, -Epidemiology, & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands;
,
Catharina C. M. Schuiling-VeningaUnit of PharmacoTherapy, -Epidemiology, & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands;
,
Jurjen van der SchansUnit of PharmacoTherapy, -Epidemiology, & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands;
,
Jens H. J. BosUnit of PharmacoTherapy, -Epidemiology, & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands;
,
Eelko HakUnit of PharmacoTherapy, -Epidemiology, & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands;
&
Petra DenigDepartment of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
 show all
Pages 1013-1019 | Received 11 Jul 2017, Accepted 12 Dec 2017, Published online: 15 Jan 2018

References

  • American Diabetes Association. Standards of medical care in diabetes – 2017. Diabetes Care 2017;40(Suppl 1):S1-S135
  • Stalman WAB, Scheltens T, Burgers JS, et al. Dutch Multidisciplinary Guideline Cardiovascular Risk Management 2006. Utrecht: CBO & NHG, 2006
  • Penning-van Beest FJ, Termorshuizen F, Goettsch WG, et al. Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study. Eur Heart J 2007;28:154-9
  • Cramer JA, Benedict Á, Muszbek N, et al. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract 2008;62:76-87
  • Slejko JF, Ho M, Anderson HD, et al. Adherence to statins in primary prevention: yearly adherence changes and outcomes. J Manag Care Pharm 2014;20:51-7
  • Donnelly LA, Doney ASF, Morris AD, et al. Long-term adherence to statin treatment in diabetes. Diabet Med 2008;25:850-5
  • de Vries FM, Voorham J, Hak E, Denig P. Adherence to standard-dose or low-dose statin treatment and low-density lipoprotein cholesterol response in type 2 diabetes patients. Curr Med Res Opin 2015;31:2197-206
  • Deshpande S, Quek RGW, Forbes CA, et al. A systematic review to assess adherence and persistence with statins. Curr Med Res Opin 2017;33:769-78
  • van Driel ML, Morledge MD, Ulep R, et al. Interventions to improve adherence to lipid-lowering medication. Cochrane Database Syst Rev 2016;12:CD004371
  • Zhang Q, Zhao C, Davies MJ, et al. Compliance and persistence with concomitant statin and oral antihyperglycemic therapy. Am J Manag Care 2011;17:746-52
  • Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012;73:691-705
  • Visser ST, Schuiling-Veninga CC, Bos JH, et al. The population-based prescription database IADB.nl: its development, usefulness in outcomes research and challenges. Expert Rev Pharmacoecon Outcomes Res 2013;13:285-92
  • Furberg CD, Pitt B. Withdrawal of cerivastatin from the world market. Curr Control Trials Cardiovasc Med 2001;2:205-7
  • Barron TI, Bennett K, Feely J. A competing risks prescription refill model of compliance and persistence. Value Heal 2010;13:796-804
  • Wilke T, Mueller S, Groth A, et al. Non-persistence and non-adherence of patients with type 2 diabetes mellitus in therapy with GLP-1 receptor agonists: a retrospective analysis. Diabetes Ther 2016;7:105-24
  • Simpson RJ, Mendys P. The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review. J Clin Lipidol 2010;4:462-71
  • Knol F, Boelhouwer J, Veldheer V. Neighbourhood status development in the Netherlands 1998–2010. The Hague: Netherlands Institute for Social Research – SCP, 2012. Available at: https://www.scp.nl/ [Last accessed 27 September 2016]
  • Jansen T, Zwaanswijk M, Hek K, de Bakker D. To what extent does sociodemographic composition of the neighbourhood explain regional differences in demand of primary out-of-hours care: a multilevel study. BMC Fam Pract 2015;16:54
  • de Vries FM, Voorham J, Hak E, Denig P. Prescribing patterns, adherence and LDL-cholesterol response of type 2 diabetes patients initiating statin on low-dose versus standard-dose treatment: a descriptive study. Int J Clin Pract 2016;70:482-92
  • Pouwels KB, Voorham J, Hak E, Denig P. Identification of major cardiovascular events in patients with diabetes using primary care data. BMC Health Serv Res 2016;16:110
  • Geers HC, Bouvy ML, Heerdink ER. Estimates of statin discontinuation rates are influenced by exposure and outcome definitions. Ann Pharmacother 2011;45:576-81
  • Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med 2005;118:27-34
  • Mann DM, Woodward M, Muntner P, et al. Predictors of nonadherence to statins: a systematic review and meta-analysis. Ann Pharmacother 2010;44:1410-21
  • Mauskop A, Borden WB. Predictors of statin adherence. Curr Cardiol Rep 2011;13:553-8
  • de Vries FM, Denig P, Vegter S, et al. Does a cardiovascular event change adherence to statin treatment in patients with type 2 diabetes? A matched cohort design. Curr Med Res Opin 2015;31:595-602
  • Ellis JJ, Erickson SR, Stevenson JG, et al. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med 2004;19:638-45
  • Zhang H, Plutzky J, Skentzos S, et al. Discontinuation of statins in routine care settings. Ann Intern Med 2013;158:526-34
  • Thompson PD, Clarkson PM, Rosenson RS. An assessment of statin safety by muscle experts. Am J Cardiol 2006;97:S69-S76

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.